Cite
HARVARD Citation
Bernat-Peguera, A. et al. (n.d.). Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data. Breast. pp. 1-9. [Online].